B of A Securities Upgrades Tyra Biosciences to Buy, Raises Price Target to $31

Benzinga · 10/18 11:29
B of A Securities analyst Geoff Meacham upgrades Tyra Biosciences (NASDAQ:TYRA) from Neutral to Buy and raises the price target from $22 to $31.